PLP1 and Pelizeaus-Merzbacher spectrum disorder: To evaluate the therapeutic potential ofPlp1 suppression in postnatal PMD mice, we tested antisenseoligonucleotides (ASOs) that stably decrease mouse Plp1 mRNA and proteinin vivo in the central nervous system.